Literature DB >> 32989553

Systematic analysis of immune-related genes based on a combination of multiple databases to build a diagnostic and a prognostic risk model for hepatocellular carcinoma.

Di-Guang Wen1, Xiao-Ping Zhao1, Yu You1, Zuo-Jin Liu2.   

Abstract

The immune microenvironment plays a vital role in the progression of hepatocellular carcinoma (HCC). Thousands of immune-related genes (IRGs) have been identified, but their effects on HCC are not fully understood. In this study, we identified the differentially expressed IRGs and analyzed their functions in HCC in a systematic way. Furthermore, we constructed a diagnostic and a prognostic model using multiple statistical methods, and both models had good distinguishing performance, which we verified in several independent datasets. This diagnostic model was also adaptable to proteomic data. The combination of a prognostic risk model and classic clinical staging can effectively distinguish patients in high- and low-risk groups. Furthermore, we systematically explore the differences in the immune microenvironment between the high-risk group and the low-risk group to help clinical decision-making. In summary, we systematically analyzed immune-related genes in HCC, explored their functions, constructed a diagnostic and a prognostic model and investigated potential therapeutic schedules in high-risk patients. The model performance was verified in multiple databases. Our findings can provide directions for future research.

Entities:  

Keywords:  Bioinformatics; Diagnostic model; Hepatocellular carcinoma; Immune microenvironment; Immune therapy; Prognostic risk model

Mesh:

Substances:

Year:  2020        PMID: 32989553     DOI: 10.1007/s00262-020-02733-2

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.968


  38 in total

1.  The CPTAC Data Portal: A Resource for Cancer Proteomics Research.

Authors:  Nathan J Edwards; Mauricio Oberti; Ratna R Thangudu; Shuang Cai; Peter B McGarvey; Shine Jacob; Subha Madhavan; Karen A Ketchum
Journal:  J Proteome Res       Date:  2015-05-04       Impact factor: 4.466

2.  The Cancer Genome Atlas: Creating Lasting Value beyond Its Data.

Authors:  Carolyn Hutter; Jean Claude Zenklusen
Journal:  Cell       Date:  2018-04-05       Impact factor: 41.582

3.  Big data mining yields novel insights on cancer.

Authors:  Peng Jiang; X Shirley Liu
Journal:  Nat Genet       Date:  2015-02       Impact factor: 38.330

4.  WGCNA Application to Proteomic and Metabolomic Data Analysis.

Authors:  G Pei; L Chen; W Zhang
Journal:  Methods Enzymol       Date:  2016-12-15       Impact factor: 1.600

Review 5.  New molecular targets for functionalized nanosized drug delivery systems in personalized therapy for hepatocellular carcinoma.

Authors:  Cristian Turato; Anna Balasso; Vinicio Carloni; Claudio Tiribelli; Francesca Mastrotto; Antonio Mazzocca; Patrizia Pontisso
Journal:  J Control Release       Date:  2017-10-16       Impact factor: 9.776

Review 6.  Challenges of combination therapy with immune checkpoint inhibitors for hepatocellular carcinoma.

Authors:  Ann-Lii Cheng; Chiun Hsu; Stephen L Chan; Su-Pin Choo; Masatoshi Kudo
Journal:  J Hepatol       Date:  2020-02       Impact factor: 25.083

Review 7.  A global view of hepatocellular carcinoma: trends, risk, prevention and management.

Authors:  Ju Dong Yang; Pierre Hainaut; Gregory J Gores; Amina Amadou; Amelie Plymoth; Lewis R Roberts
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2019-08-22       Impact factor: 73.082

8.  InnateDB: systems biology of innate immunity and beyond--recent updates and continuing curation.

Authors:  Karin Breuer; Amir K Foroushani; Matthew R Laird; Carol Chen; Anastasia Sribnaia; Raymond Lo; Geoffrey L Winsor; Robert E W Hancock; Fiona S L Brinkman; David J Lynn
Journal:  Nucleic Acids Res       Date:  2012-11-24       Impact factor: 16.971

9.  ImmPort, toward repurposing of open access immunological assay data for translational and clinical research.

Authors:  Sanchita Bhattacharya; Patrick Dunn; Cristel G Thomas; Barry Smith; Henry Schaefer; Jieming Chen; Zicheng Hu; Kelly A Zalocusky; Ravi D Shankar; Shai S Shen-Orr; Elizabeth Thomson; Jeffrey Wiser; Atul J Butte
Journal:  Sci Data       Date:  2018-02-27       Impact factor: 6.444

Review 10.  From bench to bed: the tumor immune microenvironment and current immunotherapeutic strategies for hepatocellular carcinoma.

Authors:  Yaojie Fu; Shanshan Liu; Shan Zeng; Hong Shen
Journal:  J Exp Clin Cancer Res       Date:  2019-09-09
View more
  2 in total

1.  A Novel Prognostic Model Based on Autophagy-Related Long Non-Coding RNAs for Clear Cell Renal Cell Carcinoma.

Authors:  Xinyuan Li; Haitao Yu; Zongjie Wei; Xin Gou; Simin Liang; Fu Liu
Journal:  Front Oncol       Date:  2021-08-03       Impact factor: 6.244

2.  ALKBH5/MAP3K8 axis regulates PD-L1+ macrophage infiltration and promotes hepatocellular carcinoma progression.

Authors:  Yu You; Diguang Wen; Lu Zeng; Jiao Lu; Xiao Xiao; Yucheng Chen; Hua Song; Zuojin Liu
Journal:  Int J Biol Sci       Date:  2022-08-01       Impact factor: 10.750

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.